Safety Evaluation and Adverse Events Monitoring by Poison Control Centers: A Framework for Herbs & Dietary Supplements

REFERENCES

• Morrow JD, Edeki TI, El Mouelhi M, Galinsky RE, Kovelesky R, Noveck RJ, Preuss C. Am Soc for Clin Pharmacol and Therapeutics Task Force on Dietary Supplements. American Society for Clinical Pharmacology and Therapeutics position statement on dietary supplement safety and regulation. Clin Pharmacol Ther 2005; 77: 113–122, [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• MBJ’s Annual Industry Review. VII. Nutrition Business Journal May/June, 2002
   Google Scholar
• Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Advance Data From Vital and Health Statistics, Centers for Disease Control, DHHS May 27, 2004, Number 323
   Google Scholar
• Anonymous. Dangerous supplements: still at large. Consumer Reports May 4, 2004
   Google Scholar
• Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001; 73: 1101–1106, [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• 6. Anonymous. Dietary Supplement Health and Education Act (DSHEA), Public Law 103–417, 1994. Act 21 U.S.C. 350 b [c]
   Google Scholar
• , Food & Drug Administration, Department of Health & Human Services. Medwatch Program. http://www.fda.gov/medwatch.html
   Google Scholar
• , Anonymous. FDA proposes manufacturing and labeling standards for all dietary supplements. March 7, 2003. http://www.fda.gov/bbs/topics/NEWS/dietarysupp/background.html
   Google Scholar
• , Anonymous. Dietary supplements: warnings and safety information. College Park, Maryland: FDA Center for Food Safety and Applied Nutrition. http://www.cfsan.fda.gov/~dms/ds.warn.html
   Google Scholar
• Marcus DM, Grollman AP. Botanical medicines—the need for new regulations. N Engl J Med 2002; 347: 2073–2076, [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Morrow JD, Edeki T, Mouelhi ME, Galinsky RE, Kovelesky R, et al. American Society for Clinical Pharmacology and Therapeutics position statement on dietary supplement safety and regulation. Clin Pharmacol Ther 2005; 77: 113–122, [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Committee on the Framework for Evaluating the Safety of Dietary Supplements. Institute of Medicine & National Research Council. Dietary Supplements: A Framework for Evaluating Safety. The National Academies Press, Washington, D.C 2005
   Google Scholar
• Leape L. Reporting of adverse events. N Engl J Med 2002; 347: 1633–1638, [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• 14. Inspector General Report: adverse event reporting for dietary supplements: an inadequate safety valve. Washington D.C. Office of the Inspector General. DHHS. 2001 April, report number OEI-01-00-00180
   Google Scholar
• Woolf AD, Litovitz T. Reporting of adverse events. N Engl J Med 2003; 348: 1410–1411, [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Litovitz T. The TESS database: use in product safety assessment. Drug Safety 1998; 18: 9–19, [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dennehy CE, Psourounis C, Horn AJ. Dietary supplement-related adverse events reported to the California Poison Control System. Am J Heal-Syst Pharm 2005; 62: 1476–1482, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Palmer ME, Haller C, McKinney PE, Klein-Schwartz W, Tschirgi A, Smolinske SC, Woolf A, Sprague BM, Ko R, Everson G, Nelson LS, Dodd-Butera T, Bartlett WD, Landzberg BR. Adverse events associated with dietary supplements: an observational study. Lancet 2003; 361: 101–106, [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Binscheck T, Birkhahn HJ, Felgenhauer N, Gerber-Zupan G, Zilker T, Hentschel H, Lampe D. Intoxication with alpha-lipoic acid: case reports and toxicokinetic analysis. Clin Toxicol 2005; 43: 422
   Google Scholar
• Bacis G, Farina ML. Liver transplantation for acute cholestatic hepatitis after herbal tea use. Clin Toxicol 2005; 43: 470
   Google Scholar
• Moltz E, Marshall S, Andrenyak D, Couch D, Mon M, Caravati EM, Crouch BI. Strychnine poisoning following ingestion of a Chinese herbal liniment. Clin Toxicol 2005; 43: 645
   Web of Science ®Google Scholar
• Dargan PI, Greene SL, House IM, Jones AL. Two cases of lead poisoning from Ayurvedic medicine: the tip of the iceberg?. Clin Toxicol 2005; 43: 652
   Web of Science ®Google Scholar
• Dargan PI, Dhiew CM, Greene SL, Jones AL. Yohimbine poisoning from slimming pills bought over the Internet. Clin Toxicol 2005; 43: 661
   Web of Science ®Google Scholar
• DeBellonia RR, Marcus S, Ruck B, Rella JG, Shih RD. Curandismo: consequences of folk medicine. Clin Toxicol 2005; 43: 704
   Web of Science ®Google Scholar
• Cumpston KL, Goldstein L, Monge T, Cano D. Hepatic and pulmonary veno-occlusive disease in siblings administered ELTHCHO tea. Clin Toxicol 2005; 43: 763
   Web of Science ®Google Scholar
• Pauze DK, Humberston L, Brooks DE, Katz KD. Lithium toxicity from an Internet dietary supplement. Clin Toxicol 2005; 43: 761
   Web of Science ®Google Scholar
• Smith SW, Halcomb SE, Hoffman RS, Nelson LS. A report of lupinus mutabilis anticholinergic toxicity. Clin Toxicol 2005; 43: 763
   Web of Science ®Google Scholar
• Maloney GE, Rhee JW, Schuermann T, Saeedi B, Leikin JB. Fulminant hepatic failure after using reported herbal medication containing high levels of acetaminophen. Clin Toxicol 2005; 43: 760
   Web of Science ®Google Scholar
• Watson WA, Litovitz TL, Rodgers GC, Klein-Schwartz W, Reid N, Youniss J, Flanagan A, Wruk KM. 2004 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23: 589–666, [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bent S, Tiedt TN, Odden MC, Shlipak MG. The relative safety of ephedra compared with other herbal products. Ann Intern Med 2003; 138: 468–471, [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Woolf AD, Litovtz T, Smolinske S, Watson W. The severity of toxic reactions to ephedra: comparisons to other botanical products and national trends from 1993–2002. Clin Toxicol 2005; 43(5)347–355, [CROSSREF]
   Web of Science ®Google Scholar
• Kingston R, Blumenthal M. A rational perspective on adverse events reports on herbs: misinterpretation of adverse reactions tabulated in the TESS Annual Report of the AAPCC as they relate to ephedra dietary supplements. Herbalgram 2003; 60: 48–53
   Google Scholar